All News

op.compare.jpg

2022 New ACR Guidance on Glucocorticoid-Induced Osteoporosis (GIOP)

d ACR

The ACR has updated this guideline and includes recommendations on abaloparatide (PTHrP) and romosozumab, which are newly available since the ACR’s 2017 GIOP guideline.

Read Article
joint.pain_.hand_.PIP_.jpg

70% of Older Adults Report Joint Pain

d Jack Cush, MD

Dr. Beth Wallace and colleagues at the University of Michigan surveyed a national sample of older adults (50–80 yrs) and found that 70% currently report experiencing joint pain and 60% reported being told by a health care professional that they have arthritis. 

Read Article
homunculus.JPG

Disease Activity Drives Adverse Pregnancy Outcomes in RA

d Jack Cush, MD

Two large RA registries have shown that pregnancy outcomes in rheumatoid arthritis (RA) patients is more related to RA disease activity rather than treatments use to control RA. 

Read Article
cardiac2.jpg (keep)

Gout Comes With Increased Heart Risk

d MedPage Today

Incidence of acute coronary syndrome (ACS) was significantly higher among gout patients than in the general Swedish population, researchers found, even when data were adjusted for common comorbidities.

Read Article
I just posted "Free Lupus Encyclopedia Book give away ... register to win... even international addresses are welcome" on Reddit https://t.co/Pa4h75vcW1

Links:

Donald Thomas, MD lupuscyclopedia ( View Tweet)

New download available! COVID Deaths at 3 Mos vs. 30 Mos https://t.co/SLGJGh5NX1 https://t.co/QhWdvNHntk

Links:

Dr. John Cush RheumNow ( View Tweet)
Provacative read from @VPrasadMDMPH on why we no longer need to or should wear masks in our clinics and hospitals (Yes, with COVID+ pts --- No, everywhere else). My advice: wear masks in high risk environments/situations. https://t.co/cECeieQ2YL https://t.co/PbX8xnfgqM

Links:

Dr. John Cush RheumNow ( View Tweet)
The 2022 ACR abstracts are published and posted for you. Let the Learning begin! https://t.co/ZqMAc8jV3U https://t.co/3iCGnzsPI5

Links:

Dr. John Cush RheumNow ( View Tweet)
A summary slide from #grandrounds this morning on a talk about trying to differentiate #lupus #nephritis from #preeclampsia #RheumTwitter #MedTwitter https://t.co/R2rhhgQYIm
Catherine Sims, MD DrCassySims ( View Tweet)
Mayo study of 3817 temporal artery biopsies performed on 2539 pts (1994-2004) - 681 (27%) +Bx on one side. Biopsy length HAD NO significant effect BX positivity. If 1-side initially Bx-, then Bx of the contralateral side yielded an added 7% Bx positivity https://t.co/Lr8hYHIlG7 https://t.co/alIpklPtsw

Links:

Dr. John Cush RheumNow ( View Tweet)
Taiwan population study shows increased all-cause mortality for psoriasis patients (HR 1.16; 1.13-1.19) vs. general population. https://t.co/p09mXTfXPw https://t.co/UVK3GMMmip

Links:

Dr. John Cush RheumNow ( View Tweet)
Study of 247 consecutive PsA pts shows that two-thirds (63.15%) had poor sleep quality. Poorer sleep was assoc w/ being female, higher joint counts, greater peripheral and axial disease activity, but fatigue & anxiety most explained poor sleep quality https://t.co/RTZqxtyIu9 https://t.co/OVtTQkFirD

Links:

Dr. John Cush RheumNow ( View Tweet)
Secukinumab retention in PsA: Study of 170 pts, 13% B27+, most w/ peripheral arthritis &70% on 150 mg/mo. Median retention 636 days. Peripheral arthritis was a predictor of better retention (HR 0.424). https://t.co/aZD9qD0jxm https://t.co/FlqRlcAZd1

Links:

Dr. John Cush RheumNow ( View Tweet)
The Atlantic has published an insightful article on "Brain Fog", especially as a Long Covid consequence (IMHO: Brain fogs primary cause is poor sleep, fibromyalgia, chronic fatigue - but can be complication to primary CNS events) https://t.co/SlwzRDSVSf https://t.co/qrBvV5oyUA

Links:

Dr. John Cush RheumNow ( View Tweet)
Doctor Appointment Wait Times are Up Forbes reports that a recent Merritt Hawkins survey shows that patients are waiting an average of 26 days for a scheduled appointment with a doctor. https://t.co/oJkLRzRR1y https://t.co/8zy0LgC7dt

Links:

Dr. John Cush RheumNow ( View Tweet)
TYK2 Inhibitor FDA Approved for Psoriasis BMS made a mega bet on deucravacitinib, an in-house experimental TYK2 drug, in the leadup to the big Celgene buyout, keeping it while auctioning off Celgene’s top-selling Otezla to Amgen for $13.4 billion https://t.co/wPN62jBIvL https://t.co/Cj6svOoiaJ

Links:

Dr. John Cush RheumNow ( View Tweet)
I created an online version of the Modified Rodnan Skin Score (mRSS) to make it easier to calculate References mentioned below tool: https://t.co/5Us3usCTsC @SindhuJohnson5 @Janetbirdope #scleroderma #rheum #rheumatology

Links:

A Omar ahomar ( View Tweet)

Nice table from the Poddubny et al., (2021) study which looks at some of the different characteristics between Axial SpA vs Axial PsA. Axial PsA tends to have; - Less frequent IBP - Less HLAB27 +‘ve - More frequent C-spine involvement https://t.co/XXQKBSfSQq
Charlie Clements ClementsCharl96 ( View Tweet)
In your RHEUMATOLOGY practice how often are you seeing #LongCovid (new fatigue,brainfog,breathless etc) in your immune dis pts with COVID ( i.e. > 1 month) @CCalabreseDO @jeffsparks @zach_wallace_md @philipcrobinson @JYazdanyMD @alhkim @RheumNow @EBRheum @rheum_cat @AWIRGROUP

Leonard Calabrese LCalabreseDO ( View Tweet)

The ACR is developing a new clinical practice guideline for systemic autoimmune rheumatic disease with interstitial lung disease (ILD). The Call for Public Comment is open until September 29, 2022. https://t.co/UxXDbGEQlh https://t.co/zGoBpbKLTC

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×